Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

F. Aberer; S. Kremser; J. K. Mader; W. Zinke-Cerwenka; H. Greinix; N. J. Tripolt; T. R. Pieber; A. Zebisch; H. Sill; A. Oulhaj; H. Sourij; A. Wölfler

doi:10.1016/j.diabet.2017.02.001

Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

F. Aberer
, S. Kremser
, J. K. Mader
, W. Zinke-Cerwenka
, H. Greinix
, N. J. Tripolt
, T. R. Pieber
, A. Zebisch
, H. Sill
, A. Oulhaj
, H. Sourij
, A. Wölfler

Institute of Public Health

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	560-562
Number of pages	3
Journal	Diabetes and Metabolism
Volume	43
Issue number	6
DOIs	https://doi.org/10.1016/j.diabet.2017.02.001
Publication status	Published - Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1016/j.diabet.2017.02.001

Cite this

Aberer, F., Kremser, S., Mader, J. K., Zinke-Cerwenka, W., Greinix, H., Tripolt, N. J., Pieber, T. R., Zebisch, A., Sill, H., Oulhaj, A., Sourij, H., & Wölfler, A. (2017). Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia. Diabetes and Metabolism, 43(6), 560-562. https://doi.org/10.1016/j.diabet.2017.02.001

Aberer, F, Kremser, S, Mader, JK, Zinke-Cerwenka, W, Greinix, H, Tripolt, NJ, Pieber, TR, Zebisch, A, Sill, H, Oulhaj, A, Sourij, H & Wölfler, A 2017, 'Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia', Diabetes and Metabolism, vol. 43, no. 6, pp. 560-562. https://doi.org/10.1016/j.diabet.2017.02.001

@article{618a68dd56974169b73bf8ba237f6b8c,

title = "Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia",

author = "F. Aberer and S. Kremser and Mader, \{J. K.\} and W. Zinke-Cerwenka and H. Greinix and Tripolt, \{N. J.\} and Pieber, \{T. R.\} and A. Zebisch and H. Sill and A. Oulhaj and H. Sourij and A. W{\"o}lfler",

year = "2017",

month = dec,

doi = "10.1016/j.diabet.2017.02.001",

language = "English",

volume = "43",

pages = "560--562",

journal = "Diabetes and Metabolism",

issn = "1262-3636",

publisher = "Elsevier Masson s.r.l.",

number = "6",

}

TY - JOUR

T1 - Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

AU - Aberer, F.

AU - Kremser, S.

AU - Mader, J. K.

AU - Zinke-Cerwenka, W.

AU - Greinix, H.

AU - Tripolt, N. J.

AU - Pieber, T. R.

AU - Zebisch, A.

AU - Sill, H.

AU - Oulhaj, A.

AU - Sourij, H.

AU - Wölfler, A.

PY - 2017/12

Y1 - 2017/12

UR - https://www.scopus.com/pages/publications/85014437672

UR - https://www.scopus.com/pages/publications/85014437672#tab=citedBy

U2 - 10.1016/j.diabet.2017.02.001

DO - 10.1016/j.diabet.2017.02.001

M3 - Letter

C2 - 28279650

AN - SCOPUS:85014437672

SN - 1262-3636

VL - 43

SP - 560

EP - 562

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

IS - 6

ER -

Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this